Eric OBrien - 10 May 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC

Role
Director
Signature
/s/ David Kennedy, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 May 2022
Net transactions value
$0
Form type
4
Filing time
08 Aug 2022, 10:21:03 UTC
Previous filing
04 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 10 May 2022 Common Stock 65,000 $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25,000 shares underlying the option vested or shall vest in four equal quarterly installments, the first of which shall vest on May 3, 2022. The remaining 40,000 shares underlying the option vested or shall vest in twelve equal quarterly installments, the first of which shall vest on May 3, 2022.